Galvanize Therapeutics, Inc.

Redwood City, CA

UEI
XL2XFMRTGMD7
CAGE
9ETE5
Primary NAICS
334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
SAM.gov registration
Active through

Company facts

FY2025 rankings
Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
3200 Bridge Pkwy, Redwood City, CA 94065, USA
Website
galvanizetx.com
Founded
2015
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $257,090
FY2025 $379,675
FY2024 $148,910
FY2023 $412,883

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Veterans Affairs $257,090

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Galvanize Therapeutics, Inc., a self-certified small disadvantaged business based in Redwood City, California, manufactures and sells pulsed electric field ablation systems and consumables — the Aliya System platform — exclusively to federal healthcare agencies as a prime contractor with no subcontractors. The company operates entirely on full-and-open purchase orders; all twelve awards in the source carry no set-aside designation despite the vendor's SBA small disadvantaged business status.

Galvanize's federal footprint is concentrated within the Department of Veterans Affairs healthcare network. Five VA Veterans Integrated Service Networks (VISNs 6, 8, 10, 17, and 21) account for nine of twelve awards and $879 thousand of the $1.2 million combined potential value. The National Institutes of Health Clinical Center rounds out the customer base with two awards totaling $113 thousand. VISN 6 anchors the relationship by dollar value ($336 thousand across three awards), while VISN 10 and VISN 21 each place multiple consumables and system orders. Representative work includes a $267,500 Total Small Business pulsed electric field ablation system award from VISN 8 (May 2025), a $225,000 Aliya system delivery and installation order from VISN 6 with one-year extended warranty and training (August 2023), a $182,875 Aliya ablation system and consumables purchase order from VISN 17 (September 2026), and a $75,383 pulsed electric field electrode delivery to the NIH Clinical Center (February 2023). All awards are firm fixed-price purchase orders with no parent IDIQs, GWACs, or BPAs; each transaction is standalone.

Activity has remained flat across the measurement window — four awards in 2023, four in 2024, two in 2025, and two in 2026 — with combined obligated dollars matching combined potential value at $1.2 million, indicating all awards are fully obligated. Two awards (combined potential value $257 thousand) face ultimate completion within the next twenty-four months and therefore expose the vendor to recompete. The category concentration reflects the company's single-product focus: nine awards fall under NAICS 334510 (Electromedical and Electrotherapeutic Apparatus Manufacturing), and all twelve awards carry PSC code for Medical and Surgical Instruments, Equipment, and Supplies. Galvanize competes in a narrow, device-specific niche — pulsed electric field technology for interventional bronchoscopy, lung nodule ablation, and related medical procedures — with no identified breadth into other medical device categories or therapeutic areas.

Quick answers

Is Galvanize Therapeutics, Inc. registered in SAM.gov?

Yes. Galvanize Therapeutics, Inc.'s SAM.gov registration is active through September 10, 2027.

What is Galvanize Therapeutics, Inc.'s CAGE code?

Galvanize Therapeutics, Inc.'s CAGE code is 9ETE5, and its Unique Entity ID (UEI) is XL2XFMRTGMD7.

How much has Galvanize Therapeutics, Inc. received in federal contracts?

Federal contracts obligated $379,675 to Galvanize Therapeutics, Inc. in fiscal year 2025 and $1,198,558 in fiscal years 2023 through 2027.

How does Galvanize Therapeutics, Inc. rank among federal contractors?

Galvanize Therapeutics, Inc. ranked #79 in NAICS 334510 in FY2025.

What is Galvanize Therapeutics, Inc.'s most recent federal award?

Galvanize Therapeutics, Inc.'s most recent federal contract award is Aliya ablation system and consumables (36C25626P1142), from Veterans Integrated Service Network 16 (VHA), on September 18, 2026.

On GovTribe

See Galvanize Therapeutics, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe